Travere Therapeutics (TVTX) Stock Watch: Pre‑Market Focus on the Jan. 13 FDA Decision After a 14% Rally
As of 8:54 a.m. ET in New York on Friday, December 26, 2025, U.S. markets are in pre‑market and set to reopen for the regular session at 9:30 a.m. ET. Travere Therapeutics, Inc. (NASDAQ: TVTX) is entering the post‑holiday session with fresh momentum and a very specific catalyst on investors’ minds: an FDA decision deadline of January 13, 2026 for expanding FILSPARI (sparsentan) into focal segmental glomerulosclerosis (FSGS)—a high‑stakes regulatory event that can move a biotech stock in either direction. Travere Therapeutics TVTX stock: where it stands heading into today’s open TVTX’s most recent regular-session close (Christmas Eve, Dec. 24)